Monitoring
Monitoring for respiratory decline (forced vital capacity) is recommended every 3 months, or as clinically indicated.[11][36]
Monitoring for nutrition deficit (weight and body mass index) is also recommended every 3 months, or as clinically indicated.[11]
In patients taking riluzole, monitoring for hepatotoxicity (liver function tests) and neutropenia (complete blood count) should be done every month in the first 3 months and every 3 months afterwards.[11][64][128]
Patients should be asked regularly about pain, mood disorders, and insomnia.[11]
Use of this content is subject to our disclaimer